Stock Scorecard
Stock Summary for Jazz Pharmaceuticals plc (JAZZ) - $117.77 as of 8/18/2025 10:45:41 AM EST
Total Score
8 out of 30
Safety Score
49 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for JAZZ
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JAZZ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JAZZ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JAZZ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JAZZ (49 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for JAZZ
Financial Details for JAZZ
Company Overview |
|
|---|---|
| Ticker | JAZZ |
| Company Name | Jazz Pharmaceuticals plc |
| Country | USA |
| Description | Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 117.77 |
| Price 4 Years Ago | 127.40 |
| Last Day Price Updated | 8/18/2025 10:45:41 AM EST |
| Last Day Volume | 490,613 |
| Average Daily Volume | 764,226 |
| 52-Week High | 148.06 |
| 52-Week Low | 95.49 |
| Last Price to 52 Week Low | 23.33% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 43.35 |
| Sector PE | 59.06 |
| 5-Year Average PE | 4.33 |
| Free Cash Flow Ratio | 6.00 |
| Industry Free Cash Flow Ratio | 15.81 |
| Sector Free Cash Flow Ratio | 30.26 |
| Current Ratio Most Recent Quarter | 1.62 |
| Total Cash Per Share | 19.62 |
| Book Value Per Share Most Recent Quarter | 61.12 |
| Price to Book Ratio | 1.92 |
| Industry Price to Book Ratio | 31.11 |
| Sector Price to Book Ratio | 26.93 |
| Price to Sales Ratio Twelve Trailing Months | 1.73 |
| Industry Price to Sales Ratio Twelve Trailing Months | 34.46 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.21 |
| Analyst Buy Ratings | 11 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 60,659,000 |
| Market Capitalization | 7,143,810,430 |
| Institutional Ownership | 102.58% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.75% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 118.50% |
| Annual Earnings Growth | 35.02% |
| Reported EPS 12 Trailing Months | -6.98 |
| Reported EPS Past Year | -9.77 |
| Reported EPS Prior Year | 21.19 |
| Net Income Twelve Trailing Months | -404,841,000 |
| Net Income Past Year | 560,120,000 |
| Net Income Prior Year | 414,832,000 |
| Quarterly Revenue Growth YOY | 2.10% |
| 5-Year Revenue Growth | 13.48% |
| Operating Margin Twelve Trailing Months | 20.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,189,880,000 |
| Total Cash Past Year | 2,412,864,000 |
| Total Cash Prior Year | 1,506,310,000 |
| Net Cash Position Most Recent Quarter | -3,145,736,000 |
| Net Cash Position Past Year | -3,664,776,000 |
| Long Term Debt Past Year | 6,077,640,000 |
| Long Term Debt Prior Year | 5,107,988,000 |
| Total Debt Most Recent Quarter | 4,335,616,000 |
| Equity to Debt Ratio Past Year | 0.40 |
| Equity to Debt Ratio Most Recent Quarter | 0.46 |
| Total Stockholder Equity Past Year | 4,093,756,000 |
| Total Stockholder Equity Prior Year | 3,736,997,000 |
| Total Stockholder Equity Most Recent Quarter | 3,706,359,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,240,977,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 20.46 |
| Free Cash Flow Past Year | 1,347,838,000 |
| Free Cash Flow Prior Year | 1,068,045,000 |
Options |
|
| Put/Call Ratio | 0.07 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.28 |
| MACD Signal | 0.45 |
| 20-Day Bollinger Lower Band | 99.07 |
| 20-Day Bollinger Middle Band | 109.77 |
| 20-Day Bollinger Upper Band | 120.48 |
| Beta | 0.34 |
| RSI | 58.26 |
| 50-Day SMA | 117.08 |
| 150-Day SMA | 125.47 |
| 200-Day SMA | 130.56 |
System |
|
| Modified | 8/16/2025 2:55:30 AM EST |